
Metsun Pharma India Private Limited
About Metsun Pharma India Private Limited
Data last updated:
Metsun Pharma India Private Limited is a private limited company based in Aurangabad, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 06 July 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2017PTC297027. Its GSTIN is 27AALCM1832E1ZL (Maharashtra). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Rahul Ravindra Mirkar and Sanjay Uttamrao Jadhav.
Its last annual general meeting (AGM) was held on 31 December 2018, and its latest financial statements are for the year ended 31 March 2018. The registered office is at Plot No 10 Sr No 180/6 Safayal Nager Harsul, Aurangabad, Maharashtra, India – 431001.
As per the financials filed for FY 2018, the company reported a revenue of ₹17.11 Lakh. For the same year it recorded a net profit of ₹55,446 (net margin 3.2%) and EBITDA of ₹80,240 (EBITDA margin 4.7%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Metsun Pharma India Private Limited's registered office is in Aurangabad, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot No 10 Sr No 180/6 Safayal Nager Harsul, Aurangabad, Maharashtra, India – 431001
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Metsun Pharma India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Metsun Pharma India is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Metsun Pharma India Private Limited, buy the company report.
Financials of Metsun Pharma India Private Limited
FY 2018 filings availableMetsun Pharma India Private Limited reported revenue of ₹17.11 Lakh for FY 2018.
Financial Statement Summary
| Metrics | FY 2017-18 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | ₹17.11 Lakh |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | ₹80,240 |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | ₹55,446 |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2017-18 |
|---|---|
| Profitability | |
| EBITDA Margin | 4.7% |
| Net Profit Margin | 3.2% |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Metsun Pharma India Private Limited, buy the company report.
Board of directors of Metsun Pharma India Private Limited
Metsun Pharma India has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rahul Ravindra Mirkar | Director | 06 Jul 2017 | 9 Years 3 Months | Current |
| Sanjay Uttamrao Jadhav Also directs: Livgen Healthcare LLP | Director | 06 Jul 2017 | 9 Years 3 Months | Current |
Peer comparison
Metsun Pharma India Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| SMN Pharma Private Limited | ₹17.27 Lakh (FY 2025) | 393.0% | Chennai, Tamil Nadu, India | |||
| Maverick Pharma Private Limited | ₹17.17 Lakh (FY 2025) | -72.0% | Delhi, India | |||
| Metsun Pharma India Private Limitedthis company | ₹17.11 Lakh (FY 2018) | ₹55,446 | 3.2% | Aurangabad, Maharashtra, India | ||
| Celestial Biolabs Limited | ₹16.87 Lakh (FY 2023) | 14.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Metsun Pharma India Private Limited, buy the company report.
Auditor
Metsun Pharma India Private Limited is audited by ZANWAR KHANDELWAL & ASSOCIATES for the financial year 2018.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ZANWAR KHANDELWAL & ASSOCIATES | FY 2018 | 134590W |
Shareholding
The shareholding of Metsun Pharma India Private Limited is on record for FY 2018, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2018 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Metsun Pharma India Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Metsun Pharma India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Metsun Pharma India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Metsun Pharma India has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AALCM1832E1ZL | Maharashtra | Active | 16 Aug 2017 |
| 27AALCM1832E2ZK | Maharashtra | Active | 30 Aug 2017 |
To see the full GST registrations and return filing status of Metsun Pharma India Private Limited, buy the company report.
Recent activity
Metsun Pharma India Private Limited has 2 board changes on record since 2017: 2 appointments. The latest: Rahul Ravindra Mirkar was appointed as Director on 06 Jul 2017.
Frequently asked questions
Metsun Pharma India is an active private limited company based in Aurangabad, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 06 July 2017 (9+ years old) and is registered under CIN U74999MH2017PTC297027.
Metsun Pharma India has 2 current directors:
- Rahul Ravindra Mirkar - Director
- Sanjay Uttamrao Jadhav - Director
The latest financial statements of Metsun Pharma India on record with the MCA are for the year ended 31 March 2018. Its last annual general meeting was held on 31 December 2018. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Metsun Pharma India is 27AALCM1832E1ZL, registered in Maharashtra. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 27AALCM1832E2ZK (Maharashtra).
The CIN (Corporate Identification Number) of Metsun Pharma India is U74999MH2017PTC297027. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Metsun Pharma India was incorporated on 06 July 2017, making it 9+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Metsun Pharma India by revenue are SMN Pharma Private Limited, Maverick Pharma Private Limited, Celestial Biolabs Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Rahul Ravindra Mirkar was appointed as Director on 06 Jul 2017. Sanjay Uttamrao Jadhav was appointed as Director on 06 Jul 2017.
The registered office of Metsun Pharma India is at Plot No 10 Sr No 1806 Safayal Nager Harsul, Aurangabad, Maharashtra, India – 431001.
Metsun Pharma India operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Metsun Pharma India is compliant as of 20 July 2026. The company is actively filing with the Registrar of Companies.

